Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Cancer
    February 2026
  1. O'CONNELL CP, Berndt SI, Chudy-Onwugaje K, Kunzmann A, et al
    Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Cancer. 2026;132:e70201.
    >> Share

    January 2026
  2. ALATISE OI, Owoade IA, Fayenuwo OJ, Lawal NOO, et al
    Customized early detection of colorectal cancer in Nigeria identifies advanced adenomas and early-stage disease.
    Cancer. 2026;132:e70156.
    >> Share

    December 2025
  3. FANG J, Zheng Z, Chen T, Liu J, et al
    Efficacy and safety of PD-L1 blockade envafolimab as neoadjuvant treatment in mismatch repair-deficient, locally advanced colorectal cancer: An open-label, single-arm study.
    Cancer. 2025;131:e70203.
    >> Share

  4. MYERS S, Davis ES, Franks JA, Davids JS, et al
    Beyond composite measures of regional vulnerability: Rural-urban colorectal cancer mortality disparities mediated by area-level characteristics.
    Cancer. 2025;131:e70098.
    >> Share

    October 2025
  5. FOLKERTS AD, Janczewski LM, Merkow RP
    Liver-directed therapies for colorectal liver metastases.
    Cancer. 2025;131:e70097.
    >> Share

  6. CORONADO GD, Gautom P, Schneider JL, Edelmann AC, et al
    Multilevel challenges and adaptations to patient navigation programs for colorectal cancer screening and follow-up: Findings from the Accelerating Colorectal Cancer Screening and follow-up through Implementation Science consortium.
    Cancer. 2025;131:e70121.
    >> Share

  7. BUCHLER T, Ambrozova M, Majek O, Dianova T, et al
    Risk of second primary malignancies after adjuvant chemotherapy for colon cancer.
    Cancer. 2025;131:e70116.
    >> Share

  8. KO B, Rojanasopondist P, Grady WM
    Top advances of the year: Noninvasive colorectal cancer screening tests.
    Cancer. 2025;131:e70115.
    >> Share

    September 2025
  9. STEVENS SX, Gyawali B
    CodeBreaK or code blue? Assessing sotorasib's vital signs in metastatic colorectal cancer.
    Cancer. 2025;131:e70056.
    >> Share

    August 2025
  10. TANGKA FKL, Ruiz E, Ibarra R, Hudson SM, et al
    Effectiveness and cost of implementing a patient navigation program to increase colorectal cancer screening in a large federally qualified health center.
    Cancer. 2025;131:e70031.
    >> Share

  11. NIERENGARTEN MB
    Colorectal cancer treatments show promise: Studies find longer progression-free survival and a potential relative reduction in the risk of death with treatment advances.
    Cancer. 2025;131:e70000.
    >> Share

    July 2025
  12. SCHULTZ KS, Bansal VV, Wach MM, Bhutiani N, et al
    Consensus guideline for the management of colorectal cancer with peritoneal metastases.
    Cancer. 2025;131:e35869.
    >> Share

    May 2025
  13. NIERENGARTEN MB
    Potential new standard of care for the first-line treatment of metastatic colorectal cancer: Interim analyses showed significantly better progression-free survival outcomes with the combination regimen versus either chemotherapy alone or nivolumab alo
    Cancer. 2025;131:e35854.
    >> Share

  14. STIMPSON JP, Liao JM, Morenz AM, Joo JH, et al
    A difference-in-differences analysis of Medicaid expansion and state paid sick leave laws on colorectal cancer screening.
    Cancer. 2025;131:e35904.
    >> Share

  15. NIERENGARTEN MB
    Calcium may help to protect against colorectal cancer.
    Cancer. 2025;131:e35827.
    >> Share

  16. LEE S, Ma C, Caan BJ, Binder AM, et al
    Impact of resistance training on inflammatory biomarkers and associations with treatment outcomes in colon cancer.
    Cancer. 2025;131:e35865.
    >> Share

    April 2025
  17. SUAREZ-RAMOS T, Verganza S, Pagan-Santana Y, Castaneda-Avila MA, et al
    Evaluating the impact of hurricanes and the COVID-19 pandemic on colorectal cancer incidence in Puerto Rico: An interrupted time-series analysis.
    Cancer. 2025;131:e35793.
    >> Share

  18. MACHIDA N, Okumura T, Boku N, Kishimoto J, et al
    A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G).
    Cancer. 2025;131:e35807.
    >> Share

  19. CLARKE N, Mooney T, Gallagher P, von Wagner C, et al
    Interventions to increase uptake in a fecal-immunochemical test population-based colorectal cancer screening program: A quasi-experimental study of first-time invitees.
    Cancer. 2025;131:e35760.
    >> Share

    March 2025
  20. RAYCHAUDHURI S, McLaughlin E, Pennell ML, Stefanick M, et al
    The relationship between cardiometabolic abnormalities and mortality in the Women's Health Initiative: A comparison of associations among women with cancer to women without cancer.
    Cancer. 2025;131:e35804.
    >> Share

  21. VOGTMANN E, Yano Y, Zouiouich S, Hua X, et al
    The human oral microbiome and risk of colorectal cancer within three prospective cohort studies in the United States.
    Cancer. 2025;131:e35802.
    >> Share

  22. BROWN JC, Ma C, Shi Q, Saltz LB, et al
    The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance).
    Cancer. 2025;131:e35727.
    >> Share

    February 2025
  23. ESLINGER C, Walden D, McGary A, Emiloju O, et al
    Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy.
    Cancer. 2025;131:e35756.
    >> Share

  24. BAEKER BISPO J, Jemal A, Islami F
    Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression.
    Cancer. 2025;131:e35724.
    >> Share

    January 2025
  25. PASSMAN JE, Kallan MJ, Roberson JL, Ginzberg SP, et al
    Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies.
    Cancer. 2025;131:e35664.
    >> Share

  26. NORIEGA ESQUIVES BS, Moreno PI, Munoz E, Lad TE, et al
    Effects of a culturally tailored patient navigation program on unmet supportive care needs in Hispanic/Latino cancer survivors: A randomized controlled trial.
    Cancer. 2025;131:e35626.
    >> Share

  27. PANDEY AS, Drogan C, Huo D, Postula K, et al
    Anticipation in families with MLH1-associated Lynch syndrome.
    Cancer. 2025;131:e35589.
    >> Share

    December 2024
  28. NIERENGARTEN MB
    Colorectal cancer screening and prevention: Efforts aim to optimize colonoscopy measures and broaden accessibility to screening in underserved areas.
    Cancer. 2024;130:3945.
    >> Share

    November 2024
  29. CHAI TS, Rodgers-Fouche LH, Walls JO, Mattia AR, et al
    Real-world genetic testing outcomes of pan-cancer testing for mismatch repair deficiency.
    Cancer. 2024;130:3888-3893.
    >> Share

  30. DESAI P, Zhou Y, Grenet J, Handelman SK, et al
    Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality.
    Cancer. 2024;130:3879-3887.
    >> Share

    October 2024
  31. COMPTON SLE, Yang S, Madere J, Weltzien EK, et al
    Dietary quality and chemotherapy-induced peripheral neuropathy in colon cancer.
    Cancer. 2024 Oct 5. doi: 10.1002/cncr.35599.
    >> Share

  32. SHI KS, Han X, Star J, Zhao J, et al
    Association of health insurance coverage disruptions and breast and colorectal cancer screening.
    Cancer. 2024 Oct 1. doi: 10.1002/cncr.35584.
    >> Share

    September 2024
  33. BHUTIANI N, Peacock O, Uppal A, Hu CY, et al
    The prognostic impact of tumor deposits in colorectal cancer: More than just N1c.
    Cancer. 2024 Sep 22. doi: 10.1002/cncr.35491.
    >> Share

  34. HE MM, Wang K, Song M
    Reply to "The influence of multivitamin intake on survival patterns in patients with colorectal cancer".
    Cancer. 2024 Sep 15. doi: 10.1002/cncr.35569.
    >> Share

  35. TANG WZ, Tang Y, Liu TH
    The influence of multivitamin intake on survival patterns in patients with colorectal cancer.
    Cancer. 2024 Sep 14. doi: 10.1002/cncr.35570.
    >> Share

    August 2024
  36. BEATRICI E, Paciotti M, Nguyen DD, Filipas DK, et al
    Estimating the impact of enhanced care at minority-serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers.
    Cancer. 2024;130:2770-2781.
    >> Share

  37. ISSAKA RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, et al
    Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems.
    Cancer. 2024 Aug 9. doi: 10.1002/cncr.35514.
    >> Share

  38. NIERENGARTEN MB
    Potential new therapy for KRAS-mutated CRC.
    Cancer. 2024;130:2569.
    >> Share

    July 2024
  39. SUN V, Guthrie KA, Crane TE, Arnold KB, et al
    SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer.
    Cancer. 2024;130:2384-2394.
    >> Share

    May 2024
  40. MARTINEZ ME, Roesch S, Largaespada V, Castaneda SF, et al
    A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low-income and minoritized populations.
    Cancer. 2024 May 25. doi: 10.1002/cncr.35369.
    >> Share

  41. HOEHN RS, Ammori JB, Rothermel LD, Winter JM, et al
    Providing context for the HIPECT4 results.
    Cancer. 2024;130:1727-1729.
    >> Share

  42. JANCZEWSKI LM, Browner A, Cotler J, Nelson H, et al
    Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.
    Cancer. 2024;130:1702-1710.
    >> Share

    April 2024
  43. SIMONI O, Scarpa M, Castagliuolo I, Stepanyan A, et al
    IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.
    Cancer. 2024 Apr 22. doi: 10.1002/cncr.35297.
    >> Share

  44. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.
    >> Share

  45. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.
    >> Share

    February 2024
  46. LIU YL, Weigelt B
    A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
    Cancer. 2024 Feb 29. doi: 10.1002/cncr.35267.
    >> Share

    November 2023
  47. YANG K, Doege D, Thong MSY, Koch-Gallenkamp L, et al
    Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study.
    Cancer. 2023 Nov 23. doi: 10.1002/cncr.35133.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016